|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.93 CNY | -0.50% |
|
+7.62% | -17.52% |
| Apr. 28 | Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 18 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Zhejiang Hisoar Pharmaceutical Co., Ltd. (SZSE:002099) announces a share repurchase program. Under the program, the company will repurchase up to CNY 300 million worth of its A shares. The shares will be purchased at a price not exceeding CNY 8.92 per share.
The purpose of repurchase program is to safeguard company value and shareholder rights. The program will be valid for 3 months.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.52% | 1.32B | |
| +25.83% | 661B | |
| +27.42% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.96% | 231B | |
| +5.26% | 200B | |
| -9.24% | 195B | |
| -6.26% | 145B |
ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD. 
